Governance and Protocols of the Material Review Board (MRB)

Training Module: Governance and Protocols of the Material Review Board (MRB)

1. LEARNING OBJECTIVES

In the rigorous landscape of Current Good Manufacturing Practice (cGMP), education is the primary safeguard against systemic failure. Establishing clear educational goals is the non-negotiable foundation of facility readiness; specifically, understanding the Material Review Board (MRB) protects the integrity of the manufacturing supply chain by ensuring every component meets validated standards. By mastering these protocols, professionals are equipped to prevent non-conforming materials from reaching the production floor, thereby safeguarding both the business and the patient.

Upon completion of this module, trainees will be able to:

• Identify Non-Conforming Material (NCM) and distinguish between cGMP and Non-cGMP items based on their impact on product integrity.
• Describe the cross-functional roles within the MRB, including the specific authorities of MS&T, Quality Assurance, and Finance.
• Determine the appropriate disposition for materials using criteria for "Use As Is" (UAI), "Return to Vendor" (RTV), and disposal.
• Distribute responsibility for the creation of Action Plans to remediate supplier-related risks and trends.

These objectives serve as the strategic roadmap for mastering material governance, providing the clarity needed to handle complex quality decisions with absolute precision.

2. WHY THIS MATTERS ON THE FLOOR

In sterile drug manufacturing, material integrity is not a suggestion—it is a non-negotiable mandate. The MRB acts as a critical gatekeeper for the "First Air" environment, ensuring that no component entering the high-grade production zones compromises the safety standards of the facility. Because "First Air" is the HEPA-filtered air that has not been interrupted by any equipment or personnel before reaching the exposed product, any non-conforming material introduced into this space represents a catastrophic contamination risk.

The MRB is the final line of defense for SISPQ (Safety, Identity, Strength, Purity, and Quality). The "So What?" layer is clear: if an NCM is handled incorrectly, the consequences are immediate and severe:

• Patient Safety: Contaminated or sub-potent materials can lead to ineffective treatments or life-threatening adverse reactions.
• Product Quality: Failure to identify discrepancies results in batch failures, wasting millions in resources and delaying critical medicine.
• Regulatory Non-Compliance: Unauthorized material disposition is a major red flag for health authorities, potentially leading to Consent Decrees or facility shutdowns.

Ultimately, the MRB is a pillar of "contamination control." By addressing discrepancies before they reach the production line, the board ensures the manufacturing process remains sterile and compliant. Understanding this "why" necessitates a firm grasp of the specific industry vocabulary used during these critical processes.

3. KEY TERMS & DEFINITIONS

In a GMP environment, miscommunication is a precursor to error. Adhering to a "Single Source of Truth" for terminology ensures that during high-stakes MRB meetings, every participant is aligned on the status and path forward for a material.

• MRB (Material Review Board): A panel of individuals with authority to review and address escalated materials and supplier-related issues.
• NCM (Non-Conforming Material): Any material that does not meet the established specifications or quality standards.
• SISPQ: The core pillars of product integrity: Safety, Identity, Strength, Purity, and Quality.
• UAI (Use As Is): A disposition decision where a material with a discrepancy is cleared for use without modification.
• RTV (Return to Vendor): A disposition decision to send non-conforming material back to the supplier.
• MS&T (Manufacturing Sciences & Technology): The business unit that assesses the operational impact of materials within the facility.
• QASC (Quality Assurance Supply Chain): The group responsible for the non-conforming materials process.
• MMC: The group that ensures rejected or expired material that has been segregated is processed in a timely manner.
• SME (Subject Matter Expert): An individual with direct knowledge of a job and the specific skills/characteristics required to perform it successfully.
• CCB (Change Control Board): Not covered in current sources.
• LIR (Laboratory Incident Report): Not covered in current sources.

These definitions are the building blocks for the procedural steps that follow.

4. THE PROCEDURE, STEP BY STEP (WITH THE "WHY")

The MRB process is a structured, multi-disciplinary approach to risk management rather than a simple administrative meeting. Every step is designed to ensure decisions are data-driven and legally defensible.

Step 1: MRB Preparation and Initiation

The process begins when an Initiator brings a request for a decision to the MRB. This involves gathering all technical data regarding the NCM to present to the board.

• Rationale/Risk Control: The Initiator serves as the vital bridge between a physical discrepancy and the board. This prevents "ghost issues" from entering the system without a technical owner and ensures the board has sufficient data to make an informed decision.